Corcept Therapeutics CORT Deferred Tax Assets
Deferred Tax Assets at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxAssetsNet.
The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corcept Therapeutics's deferred tax assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corcept Therapeutics's deferred tax assets?
- Corcept Therapeutics (CORT) reported deferred tax assets of $181.56M in Q1 2026.
- How has Corcept Therapeutics's deferred tax assets changed year-over-year?
- Corcept Therapeutics's deferred tax assets increased by 25.7% year-over-year, from $144.45M to $181.56M.
- What is the long-term trend for Corcept Therapeutics's deferred tax assets?
- Over 5 years (2020 to 2025), Corcept Therapeutics's deferred tax assets has grown at a 39.7% compound annual growth rate (CAGR), from $31.6M to $168.2M.